• Basic Protein Native PAGE Gel Kit: Optimizing Native Protein

  2026-06-10

  The Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) from APExBIO empowers researchers to separate and analyze acidic proteins while preserving their native conformation and activity. This article details proven workflows, advanced applications, and troubleshooting strategies that maximize reproducibility and biological insight in native protein gel electrophoresis.

• SIS3 (Smad3 Inhibitor): Precision Control in Fibrosis Resear

  2026-06-10

  SIS3 delivers highly selective Smad3 inhibition, empowering researchers to dissect the TGF-β signaling pathway with minimal off-target effects. Its versatility in fibrosis, renal disease, and oncology models makes it an indispensable tool for mechanistic and translational studies.

• Strategic RNA Synthesis: Accelerating Antiviral Discovery wi

  2026-06-09

  This thought-leadership article explores how the HyperScribe™ T7 High Yield RNA Synthesis Kit from APExBIO empowers translational researchers to dissect viral translation mechanisms and accelerate the development of novel antivirals. By bridging mechanistic insights from Senecavirus A IRES-targeting studies with practical protocol guidance and workflow strategy, the article highlights both the scientific and operational advantages of leveraging high-yield in vitro transcription for RNA-centric discovery.

• HBsAg Manipulation of TBK1: Suppression of Interferon and Au

  2026-06-09

  The reference study uncovers how hepatitis B surface antigen (HBsAg) hijacks TANK-binding kinase 1 (TBK1) to suppress type I interferon signaling while simultaneously inducing early autophagy in host cells. This dual mechanism reveals new insights into how HBV evades innate immunity and sustains persistent infection, with implications for therapeutic research targeting viral-host interactions.

• Macrophage-Targeted mRNA-LNPs Enhance Spinal Cord Injury Rec

  2026-06-08

  Fu et al. (2025) demonstrate that intravenously delivered, macrophage-targeted Mms6 mRNA-lipid nanoparticles (LNPs) significantly improve locomotor recovery in mice after spinal cord injury. This strategy leverages targeted mRNA delivery to endogenous macrophages to promote neuronal repair and reduce lesion pathology, highlighting a promising approach for non-invasive, cell-specific gene therapy in neuroregeneration.

• IPA-3: Applied Pak1 Inhibition for Advanced Kinase Assays

  2026-06-08

  IPA-3 (1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol) provides selective, non-ATP-competitive Pak1 inhibition, enabling precise dissection of cell signaling in cancer and neuroinflammation research. This article delivers actionable protocols, troubleshooting insights, and cross-domain context to maximize reproducibility and impact in translational workflows.

• Safe DNA Gel Stain: Elevating Nucleic Acid Detection Precisi

  2026-06-07

  Explore how Safe DNA Gel Stain advances DNA and RNA gel stain protocols by enhancing sensitivity, safety, and experimental reproducibility. This article delivers a mechanistic deep dive and practical assay guidance beyond conventional overviews.

• Tropisetron Hydrochloride: Precision Tools for Translational

  2026-06-06

  This thought-leadership article explores the dual mechanistic roles of Tropisetron Hydrochloride as a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist. Bridging neuropharmacology with renal transporter research, we provide actionable insights for translational scientists, integrating recent transporter interaction data, workflow parameters, and competitive positioning. APExBIO’s high-purity Tropisetron Hydrochloride is spotlighted as a foundational reagent for those advancing serotonin receptor signaling and transporter modulation studies.

• HMGB1 as an Early Serum Biomarker in Diabetic Nephropathy Pr

  2026-06-05

  This study employs quantitative proteomics to identify HMGB1 as a promising serum biomarker for early detection and monitoring of diabetic nephropathy (DN). The findings highlight HMGB1’s potential utility in improving noninvasive DN diagnostics and risk stratification.

• Disrupting DDX3X Drives Ferroptosis in KRAS-Driven Lung Canc

  2026-06-05

  This study identifies DDX3X as a critical regulator of antioxidative homeostasis in KRAS-driven lung cancer. Targeting DDX3X impairs cysteine and glutathione metabolism, inducing ferroptosis and suppressing tumor progression—highlighting DDX3X as a promising therapeutic target for overcoming resistance to KRAS inhibitors.

• Arachidonic Acid Workflows: Optimizing Inflammation Assays

  2026-06-04

  Arachidonic Acid is the gold-standard polyunsaturated omega-6 fatty acid for modeling eicosanoid-driven inflammation and neuroimmune responses. This guide integrates protocol enhancements, cross-platform troubleshooting, and lessons from translational stroke research to help labs maximize data quality and biological relevance.

• Romidepsin (FK228): Optimizing HDAC Inhibitor Workflows in C

  2026-06-04

  Romidepsin (FK228) stands out as a selective HDAC inhibitor driving breakthroughs in epigenetic modulation, especially in spliceosome-targeted cancer models. This article translates the latest reference findings into actionable protocols and troubleshooting strategies, spotlighting Romidepsin’s unique role in sensitizing hepatocellular carcinoma to PARP inhibitors.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-06-03

  The reference study uncovers how certain kinase inhibitors not only block p38α MAP kinase activity but also actively promote its dephosphorylation by stabilizing a conformation more accessible to phosphatases. This dual-action mechanism provides new strategies for achieving specificity and potency in the modulation of inflammation signaling and vascular functions.

• Deciphering P. aeruginosa Resistance: ampC/ampD Mutations vi

  2026-06-03

  This study employs semi-mechanistic pharmacokinetic/pharmacodynamic modeling to unravel the contributions of specific ampC and ampD mutations to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa. The findings enable fine-grained discrimination between acquired and adaptive resistance mechanisms, offering new avenues for translational antibiotic resistance research.

• WY-14643 (Pirinixic Acid): Illuminating PPARα in Tumor and M

  2026-06-02

  Explore how WY-14643 (Pirinixic Acid) enables advanced metabolic and tumor microenvironment research by precisely modulating PPARα pathways. This article uniquely bridges recent omics findings with practical assay guidance and protocol insights.

16940 records 1/1130 page Next 12345 下5页 Last page